Global Gene Therapy in Cardiovascular Disorder Market Growth (Status and Outlook) 2026-2032
The global Gene Therapy in Cardiovascular Disorder market size is predicted to grow from US$ 593 million in 2025 to US$ 2317 million in 2032; it is expected to grow at a CAGR of 21.9% from 2026 to 2032.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gene Therapy in Cardiovascular Disorder Industry Forecast” looks at past sales and reviews total world Gene Therapy in Cardiovascular Disorder sales in 2025, providing a comprehensive analysis by region and market sector of projected Gene Therapy in Cardiovascular Disorder sales for 2026 through 2032. With Gene Therapy in Cardiovascular Disorder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy in Cardiovascular Disorder industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy in Cardiovascular Disorder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapy in Cardiovascular Disorder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy in Cardiovascular Disorder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy in Cardiovascular Disorder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy in Cardiovascular Disorder.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy in Cardiovascular Disorder market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gene Therapy in Cardiovascular Disorder Industry Forecast” looks at past sales and reviews total world Gene Therapy in Cardiovascular Disorder sales in 2025, providing a comprehensive analysis by region and market sector of projected Gene Therapy in Cardiovascular Disorder sales for 2026 through 2032. With Gene Therapy in Cardiovascular Disorder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy in Cardiovascular Disorder industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy in Cardiovascular Disorder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapy in Cardiovascular Disorder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy in Cardiovascular Disorder market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy in Cardiovascular Disorder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy in Cardiovascular Disorder.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy in Cardiovascular Disorder market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Viral Gene Therapy
- Non-viral Gene Therapy
- Heart Disease
- Vascular Disease
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Renovacor
- Gene Biotherapeutics
- AskBio
- Human Stem Cells Institute
- Novartis
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy in Cardiovascular Disorder Market Size (2021-2032)
2.1.2 Gene Therapy in Cardiovascular Disorder Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Gene Therapy in Cardiovascular Disorder by Country/Region (2021, 2025 & 2032)
2.2 Gene Therapy in Cardiovascular Disorder Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-viral Gene Therapy
2.2.3 Gene Therapy in Cardiovascular Disorder Market Size by Type
2.2.3.1 Gene Therapy in Cardiovascular Disorder Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
2.3 Gene Therapy in Cardiovascular Disorder Segment by Application
2.3.1 Heart Disease
2.3.2 Vascular Disease
2.3.3 Gene Therapy in Cardiovascular Disorder Market Size by Application
2.3.3.1 Gene Therapy in Cardiovascular Disorder Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
3 GENE THERAPY IN CARDIOVASCULAR DISORDER MARKET SIZE BY PLAYER
3.1 Gene Therapy in Cardiovascular Disorder Market Size Market Share by Player
3.1.1 Global Gene Therapy in Cardiovascular Disorder Revenue by Player (2021-2026)
3.1.2 Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Player (2021-2026)
3.2 Global Gene Therapy in Cardiovascular Disorder Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY IN CARDIOVASCULAR DISORDER BY REGION
4.1 Gene Therapy in Cardiovascular Disorder Market Size by Region (2021-2026)
4.2 Global Gene Therapy in Cardiovascular Disorder Annual Revenue by Country/Region (2021-2026)
4.3 Americas Gene Therapy in Cardiovascular Disorder Market Size Growth (2021-2026)
4.4 APAC Gene Therapy in Cardiovascular Disorder Market Size Growth (2021-2026)
4.5 Europe Gene Therapy in Cardiovascular Disorder Market Size Growth (2021-2026)
4.6 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Gene Therapy in Cardiovascular Disorder Market Size by Country (2021-2026)
5.2 Americas Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026)
5.3 Americas Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy in Cardiovascular Disorder Market Size by Region (2021-2026)
6.2 APAC Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026)
6.3 APAC Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2021-2026)
7.2 Europe Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026)
7.3 Europe Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy in Cardiovascular Disorder by Region (2021-2026)
8.2 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026)
8.3 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY IN CARDIOVASCULAR DISORDER MARKET FORECAST
10.1 Global Gene Therapy in Cardiovascular Disorder Forecast by Region (2027-2032)
10.1.1 Global Gene Therapy in Cardiovascular Disorder Forecast by Region (2027-2032)
10.1.2 Americas Gene Therapy in Cardiovascular Disorder Forecast
10.1.3 APAC Gene Therapy in Cardiovascular Disorder Forecast
10.1.4 Europe Gene Therapy in Cardiovascular Disorder Forecast
10.1.5 Middle East & Africa Gene Therapy in Cardiovascular Disorder Forecast
10.2 Americas Gene Therapy in Cardiovascular Disorder Forecast by Country (2027-2032)
10.2.1 United States Market Gene Therapy in Cardiovascular Disorder Forecast
10.2.2 Canada Market Gene Therapy in Cardiovascular Disorder Forecast
10.2.3 Mexico Market Gene Therapy in Cardiovascular Disorder Forecast
10.2.4 Brazil Market Gene Therapy in Cardiovascular Disorder Forecast
10.3 APAC Gene Therapy in Cardiovascular Disorder Forecast by Region (2027-2032)
10.3.1 China Gene Therapy in Cardiovascular Disorder Market Forecast
10.3.2 Japan Market Gene Therapy in Cardiovascular Disorder Forecast
10.3.3 Korea Market Gene Therapy in Cardiovascular Disorder Forecast
10.3.4 Southeast Asia Market Gene Therapy in Cardiovascular Disorder Forecast
10.3.5 India Market Gene Therapy in Cardiovascular Disorder Forecast
10.3.6 Australia Market Gene Therapy in Cardiovascular Disorder Forecast
10.4 Europe Gene Therapy in Cardiovascular Disorder Forecast by Country (2027-2032)
10.4.1 Germany Market Gene Therapy in Cardiovascular Disorder Forecast
10.4.2 France Market Gene Therapy in Cardiovascular Disorder Forecast
10.4.3 UK Market Gene Therapy in Cardiovascular Disorder Forecast
10.4.4 Italy Market Gene Therapy in Cardiovascular Disorder Forecast
10.4.5 Russia Market Gene Therapy in Cardiovascular Disorder Forecast
10.5 Middle East & Africa Gene Therapy in Cardiovascular Disorder Forecast by Region (2027-2032)
10.5.1 Egypt Market Gene Therapy in Cardiovascular Disorder Forecast
10.5.2 South Africa Market Gene Therapy in Cardiovascular Disorder Forecast
10.5.3 Israel Market Gene Therapy in Cardiovascular Disorder Forecast
10.5.4 Turkey Market Gene Therapy in Cardiovascular Disorder Forecast
10.6 Global Gene Therapy in Cardiovascular Disorder Forecast by Type (2027-2032)
10.7 Global Gene Therapy in Cardiovascular Disorder Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Gene Therapy in Cardiovascular Disorder Forecast
11 KEY PLAYERS ANALYSIS
11.1 Renovacor
11.1.1 Renovacor Company Information
11.1.2 Renovacor Gene Therapy in Cardiovascular Disorder Product Offered
11.1.3 Renovacor Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Renovacor Main Business Overview
11.1.5 Renovacor Latest Developments
11.2 Gene Biotherapeutics
11.2.1 Gene Biotherapeutics Company Information
11.2.2 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Product Offered
11.2.3 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gene Biotherapeutics Main Business Overview
11.2.5 Gene Biotherapeutics Latest Developments
11.3 AskBio
11.3.1 AskBio Company Information
11.3.2 AskBio Gene Therapy in Cardiovascular Disorder Product Offered
11.3.3 AskBio Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 AskBio Main Business Overview
11.3.5 AskBio Latest Developments
11.4 Human Stem Cells Institute
11.4.1 Human Stem Cells Institute Company Information
11.4.2 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Product Offered
11.4.3 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Human Stem Cells Institute Main Business Overview
11.4.5 Human Stem Cells Institute Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Gene Therapy in Cardiovascular Disorder Product Offered
11.5.3 Novartis Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy in Cardiovascular Disorder Market Size (2021-2032)
2.1.2 Gene Therapy in Cardiovascular Disorder Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Gene Therapy in Cardiovascular Disorder by Country/Region (2021, 2025 & 2032)
2.2 Gene Therapy in Cardiovascular Disorder Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-viral Gene Therapy
2.2.3 Gene Therapy in Cardiovascular Disorder Market Size by Type
2.2.3.1 Gene Therapy in Cardiovascular Disorder Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
2.3 Gene Therapy in Cardiovascular Disorder Segment by Application
2.3.1 Heart Disease
2.3.2 Vascular Disease
2.3.3 Gene Therapy in Cardiovascular Disorder Market Size by Application
2.3.3.1 Gene Therapy in Cardiovascular Disorder Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
3 GENE THERAPY IN CARDIOVASCULAR DISORDER MARKET SIZE BY PLAYER
3.1 Gene Therapy in Cardiovascular Disorder Market Size Market Share by Player
3.1.1 Global Gene Therapy in Cardiovascular Disorder Revenue by Player (2021-2026)
3.1.2 Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Player (2021-2026)
3.2 Global Gene Therapy in Cardiovascular Disorder Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY IN CARDIOVASCULAR DISORDER BY REGION
4.1 Gene Therapy in Cardiovascular Disorder Market Size by Region (2021-2026)
4.2 Global Gene Therapy in Cardiovascular Disorder Annual Revenue by Country/Region (2021-2026)
4.3 Americas Gene Therapy in Cardiovascular Disorder Market Size Growth (2021-2026)
4.4 APAC Gene Therapy in Cardiovascular Disorder Market Size Growth (2021-2026)
4.5 Europe Gene Therapy in Cardiovascular Disorder Market Size Growth (2021-2026)
4.6 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Gene Therapy in Cardiovascular Disorder Market Size by Country (2021-2026)
5.2 Americas Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026)
5.3 Americas Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy in Cardiovascular Disorder Market Size by Region (2021-2026)
6.2 APAC Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026)
6.3 APAC Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2021-2026)
7.2 Europe Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026)
7.3 Europe Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy in Cardiovascular Disorder by Region (2021-2026)
8.2 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026)
8.3 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY IN CARDIOVASCULAR DISORDER MARKET FORECAST
10.1 Global Gene Therapy in Cardiovascular Disorder Forecast by Region (2027-2032)
10.1.1 Global Gene Therapy in Cardiovascular Disorder Forecast by Region (2027-2032)
10.1.2 Americas Gene Therapy in Cardiovascular Disorder Forecast
10.1.3 APAC Gene Therapy in Cardiovascular Disorder Forecast
10.1.4 Europe Gene Therapy in Cardiovascular Disorder Forecast
10.1.5 Middle East & Africa Gene Therapy in Cardiovascular Disorder Forecast
10.2 Americas Gene Therapy in Cardiovascular Disorder Forecast by Country (2027-2032)
10.2.1 United States Market Gene Therapy in Cardiovascular Disorder Forecast
10.2.2 Canada Market Gene Therapy in Cardiovascular Disorder Forecast
10.2.3 Mexico Market Gene Therapy in Cardiovascular Disorder Forecast
10.2.4 Brazil Market Gene Therapy in Cardiovascular Disorder Forecast
10.3 APAC Gene Therapy in Cardiovascular Disorder Forecast by Region (2027-2032)
10.3.1 China Gene Therapy in Cardiovascular Disorder Market Forecast
10.3.2 Japan Market Gene Therapy in Cardiovascular Disorder Forecast
10.3.3 Korea Market Gene Therapy in Cardiovascular Disorder Forecast
10.3.4 Southeast Asia Market Gene Therapy in Cardiovascular Disorder Forecast
10.3.5 India Market Gene Therapy in Cardiovascular Disorder Forecast
10.3.6 Australia Market Gene Therapy in Cardiovascular Disorder Forecast
10.4 Europe Gene Therapy in Cardiovascular Disorder Forecast by Country (2027-2032)
10.4.1 Germany Market Gene Therapy in Cardiovascular Disorder Forecast
10.4.2 France Market Gene Therapy in Cardiovascular Disorder Forecast
10.4.3 UK Market Gene Therapy in Cardiovascular Disorder Forecast
10.4.4 Italy Market Gene Therapy in Cardiovascular Disorder Forecast
10.4.5 Russia Market Gene Therapy in Cardiovascular Disorder Forecast
10.5 Middle East & Africa Gene Therapy in Cardiovascular Disorder Forecast by Region (2027-2032)
10.5.1 Egypt Market Gene Therapy in Cardiovascular Disorder Forecast
10.5.2 South Africa Market Gene Therapy in Cardiovascular Disorder Forecast
10.5.3 Israel Market Gene Therapy in Cardiovascular Disorder Forecast
10.5.4 Turkey Market Gene Therapy in Cardiovascular Disorder Forecast
10.6 Global Gene Therapy in Cardiovascular Disorder Forecast by Type (2027-2032)
10.7 Global Gene Therapy in Cardiovascular Disorder Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Gene Therapy in Cardiovascular Disorder Forecast
11 KEY PLAYERS ANALYSIS
11.1 Renovacor
11.1.1 Renovacor Company Information
11.1.2 Renovacor Gene Therapy in Cardiovascular Disorder Product Offered
11.1.3 Renovacor Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Renovacor Main Business Overview
11.1.5 Renovacor Latest Developments
11.2 Gene Biotherapeutics
11.2.1 Gene Biotherapeutics Company Information
11.2.2 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Product Offered
11.2.3 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gene Biotherapeutics Main Business Overview
11.2.5 Gene Biotherapeutics Latest Developments
11.3 AskBio
11.3.1 AskBio Company Information
11.3.2 AskBio Gene Therapy in Cardiovascular Disorder Product Offered
11.3.3 AskBio Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 AskBio Main Business Overview
11.3.5 AskBio Latest Developments
11.4 Human Stem Cells Institute
11.4.1 Human Stem Cells Institute Company Information
11.4.2 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Product Offered
11.4.3 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Human Stem Cells Institute Main Business Overview
11.4.5 Human Stem Cells Institute Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Gene Therapy in Cardiovascular Disorder Product Offered
11.5.3 Novartis Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapy in Cardiovascular Disorder Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Gene Therapy in Cardiovascular Disorder Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Viral Gene Therapy
Table 4. Major Players of Non-viral Gene Therapy
Table 5. Gene Therapy in Cardiovascular Disorder Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
Table 8. Gene Therapy in Cardiovascular Disorder Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
Table 11. Global Gene Therapy in Cardiovascular Disorder Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Player (2021-2026)
Table 13. Gene Therapy in Cardiovascular Disorder Key Players Head office and Products Offered
Table 14. Gene Therapy in Cardiovascular Disorder Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Therapy in Cardiovascular Disorder Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Region (2021-2026)
Table 19. Global Gene Therapy in Cardiovascular Disorder Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Gene Therapy in Cardiovascular Disorder Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Gene Therapy in Cardiovascular Disorder Market Size Market Share by Country (2021-2026)
Table 23. Americas Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
Table 25. Americas Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
Table 27. APAC Gene Therapy in Cardiovascular Disorder Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Gene Therapy in Cardiovascular Disorder Market Size Market Share by Region (2021-2026)
Table 29. APAC Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Gene Therapy in Cardiovascular Disorder Market Size Market Share by Country (2021-2026)
Table 33. Europe Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Therapy in Cardiovascular Disorder
Table 39. Key Market Challenges & Risks of Gene Therapy in Cardiovascular Disorder
Table 40. Key Industry Trends of Gene Therapy in Cardiovascular Disorder
Table 41. Global Gene Therapy in Cardiovascular Disorder Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Gene Therapy in Cardiovascular Disorder Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Gene Therapy in Cardiovascular Disorder Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Renovacor Details, Company Type, Gene Therapy in Cardiovascular Disorder Area Served and Its Competitors
Table 46. Renovacor Gene Therapy in Cardiovascular Disorder Product Offered
Table 47. Renovacor Gene Therapy in Cardiovascular Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Renovacor Main Business
Table 49. Renovacor Latest Developments
Table 50. Gene Biotherapeutics Details, Company Type, Gene Therapy in Cardiovascular Disorder Area Served and Its Competitors
Table 51. Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Product Offered
Table 52. Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Gene Biotherapeutics Main Business
Table 54. Gene Biotherapeutics Latest Developments
Table 55. AskBio Details, Company Type, Gene Therapy in Cardiovascular Disorder Area Served and Its Competitors
Table 56. AskBio Gene Therapy in Cardiovascular Disorder Product Offered
Table 57. AskBio Gene Therapy in Cardiovascular Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. AskBio Main Business
Table 59. AskBio Latest Developments
Table 60. Human Stem Cells Institute Details, Company Type, Gene Therapy in Cardiovascular Disorder Area Served and Its Competitors
Table 61. Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Product Offered
Table 62. Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Human Stem Cells Institute Main Business
Table 64. Human Stem Cells Institute Latest Developments
Table 65. Novartis Details, Company Type, Gene Therapy in Cardiovascular Disorder Area Served and Its Competitors
Table 66. Novartis Gene Therapy in Cardiovascular Disorder Product Offered
Table 67. Novartis Gene Therapy in Cardiovascular Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Novartis Main Business
Table 69. Novartis Latest Developments
Table 1. Gene Therapy in Cardiovascular Disorder Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Gene Therapy in Cardiovascular Disorder Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Viral Gene Therapy
Table 4. Major Players of Non-viral Gene Therapy
Table 5. Gene Therapy in Cardiovascular Disorder Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
Table 8. Gene Therapy in Cardiovascular Disorder Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
Table 11. Global Gene Therapy in Cardiovascular Disorder Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Player (2021-2026)
Table 13. Gene Therapy in Cardiovascular Disorder Key Players Head office and Products Offered
Table 14. Gene Therapy in Cardiovascular Disorder Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Therapy in Cardiovascular Disorder Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Region (2021-2026)
Table 19. Global Gene Therapy in Cardiovascular Disorder Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Gene Therapy in Cardiovascular Disorder Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Gene Therapy in Cardiovascular Disorder Market Size Market Share by Country (2021-2026)
Table 23. Americas Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
Table 25. Americas Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
Table 27. APAC Gene Therapy in Cardiovascular Disorder Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Gene Therapy in Cardiovascular Disorder Market Size Market Share by Region (2021-2026)
Table 29. APAC Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Gene Therapy in Cardiovascular Disorder Market Size Market Share by Country (2021-2026)
Table 33. Europe Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Therapy in Cardiovascular Disorder
Table 39. Key Market Challenges & Risks of Gene Therapy in Cardiovascular Disorder
Table 40. Key Industry Trends of Gene Therapy in Cardiovascular Disorder
Table 41. Global Gene Therapy in Cardiovascular Disorder Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Gene Therapy in Cardiovascular Disorder Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Gene Therapy in Cardiovascular Disorder Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Renovacor Details, Company Type, Gene Therapy in Cardiovascular Disorder Area Served and Its Competitors
Table 46. Renovacor Gene Therapy in Cardiovascular Disorder Product Offered
Table 47. Renovacor Gene Therapy in Cardiovascular Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Renovacor Main Business
Table 49. Renovacor Latest Developments
Table 50. Gene Biotherapeutics Details, Company Type, Gene Therapy in Cardiovascular Disorder Area Served and Its Competitors
Table 51. Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Product Offered
Table 52. Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Gene Biotherapeutics Main Business
Table 54. Gene Biotherapeutics Latest Developments
Table 55. AskBio Details, Company Type, Gene Therapy in Cardiovascular Disorder Area Served and Its Competitors
Table 56. AskBio Gene Therapy in Cardiovascular Disorder Product Offered
Table 57. AskBio Gene Therapy in Cardiovascular Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. AskBio Main Business
Table 59. AskBio Latest Developments
Table 60. Human Stem Cells Institute Details, Company Type, Gene Therapy in Cardiovascular Disorder Area Served and Its Competitors
Table 61. Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Product Offered
Table 62. Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Human Stem Cells Institute Main Business
Table 64. Human Stem Cells Institute Latest Developments
Table 65. Novartis Details, Company Type, Gene Therapy in Cardiovascular Disorder Area Served and Its Competitors
Table 66. Novartis Gene Therapy in Cardiovascular Disorder Product Offered
Table 67. Novartis Gene Therapy in Cardiovascular Disorder Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Novartis Main Business
Table 69. Novartis Latest Developments
LIST OF FIGURES
Figure 1. Gene Therapy in Cardiovascular Disorder Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy in Cardiovascular Disorder Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Gene Therapy in Cardiovascular Disorder Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Gene Therapy in Cardiovascular Disorder Sales Market Share by Country/Region (2025)
Figure 8. Gene Therapy in Cardiovascular Disorder Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type in 2025
Figure 10. Gene Therapy in Cardiovascular Disorder in Heart Disease
Figure 11. Global Gene Therapy in Cardiovascular Disorder Market: Heart Disease (2021-2026) & ($ millions)
Figure 12. Gene Therapy in Cardiovascular Disorder in Vascular Disease
Figure 13. Global Gene Therapy in Cardiovascular Disorder Market: Vascular Disease (2021-2026) & ($ millions)
Figure 14. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application in 2025
Figure 15. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Player in 2025
Figure 16. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Region (2021-2026)
Figure 17. Americas Gene Therapy in Cardiovascular Disorder Market Size 2021-2026 ($ millions)
Figure 18. APAC Gene Therapy in Cardiovascular Disorder Market Size 2021-2026 ($ millions)
Figure 19. Europe Gene Therapy in Cardiovascular Disorder Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size 2021-2026 ($ millions)
Figure 21. Americas Gene Therapy in Cardiovascular Disorder Value Market Share by Country in 2025
Figure 22. United States Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Gene Therapy in Cardiovascular Disorder Market Size Market Share by Region in 2025
Figure 27. APAC Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
Figure 28. APAC Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
Figure 29. China Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 33. India Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Gene Therapy in Cardiovascular Disorder Market Size Market Share by Country in 2025
Figure 36. Europe Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
Figure 37. Europe Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
Figure 38. Germany Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 39. France Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 52. APAC Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 53. Europe Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 55. United States Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 56. Canada Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 57. Mexico Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 58. Brazil Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 59. China Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 60. Japan Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 61. Korea Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 63. India Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 64. Australia Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 65. Germany Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 66. France Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 67. UK Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 68. Italy Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 69. Russia Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 70. Egypt Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 71. South Africa Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 72. Israel Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 73. Turkey Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 74. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 1. Gene Therapy in Cardiovascular Disorder Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy in Cardiovascular Disorder Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Gene Therapy in Cardiovascular Disorder Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Gene Therapy in Cardiovascular Disorder Sales Market Share by Country/Region (2025)
Figure 8. Gene Therapy in Cardiovascular Disorder Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type in 2025
Figure 10. Gene Therapy in Cardiovascular Disorder in Heart Disease
Figure 11. Global Gene Therapy in Cardiovascular Disorder Market: Heart Disease (2021-2026) & ($ millions)
Figure 12. Gene Therapy in Cardiovascular Disorder in Vascular Disease
Figure 13. Global Gene Therapy in Cardiovascular Disorder Market: Vascular Disease (2021-2026) & ($ millions)
Figure 14. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application in 2025
Figure 15. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Player in 2025
Figure 16. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share by Region (2021-2026)
Figure 17. Americas Gene Therapy in Cardiovascular Disorder Market Size 2021-2026 ($ millions)
Figure 18. APAC Gene Therapy in Cardiovascular Disorder Market Size 2021-2026 ($ millions)
Figure 19. Europe Gene Therapy in Cardiovascular Disorder Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size 2021-2026 ($ millions)
Figure 21. Americas Gene Therapy in Cardiovascular Disorder Value Market Share by Country in 2025
Figure 22. United States Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Gene Therapy in Cardiovascular Disorder Market Size Market Share by Region in 2025
Figure 27. APAC Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
Figure 28. APAC Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
Figure 29. China Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 33. India Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Gene Therapy in Cardiovascular Disorder Market Size Market Share by Country in 2025
Figure 36. Europe Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
Figure 37. Europe Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
Figure 38. Germany Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 39. France Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Gene Therapy in Cardiovascular Disorder Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 52. APAC Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 53. Europe Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 55. United States Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 56. Canada Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 57. Mexico Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 58. Brazil Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 59. China Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 60. Japan Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 61. Korea Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 63. India Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 64. Australia Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 65. Germany Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 66. France Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 67. UK Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 68. Italy Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 69. Russia Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 70. Egypt Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 71. South Africa Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 72. Israel Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 73. Turkey Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
Figure 74. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Gene Therapy in Cardiovascular Disorder Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Gene Therapy in Cardiovascular Disorder Market Size 2027-2032 ($ millions)
